• Early data from Mithra’s ESTELLE® pediatric study to be presented at two upcoming congresses

    Wednesday April 17th 2024

  • Mithra reaches milestone in estetrol skin study

    Tuesday April 9th 2024

  • Strong data from Sequana Medical's DSR® proof-of-concept studies in heart failure published in European Journal of Heart Failure

    Wednesday April 3rd 2024

  • Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering

    Wednesday March 13th 2024

  • KU Leuven researchers discover how to break the negative feedback loop to improve cancer immunotherapy

    Tuesday January 16th 2024

  • Sequana Medical granted US CPT® III reimbursement codes for alfapump® system

    Wednesday January 3rd 2024

  • Orionis Biosciences announces first patient dosed in Phase 1 clinical trial of ORB-011 in patients with advanced solid tumors

    Wednesday November 15th 2023

  • SwiftPharma and PlantForm target blockbuster cancer drug with new contract manufacturing agreement for plant-made biosimilars

    Tuesday November 14th 2023

  • Your news here?

  • Belgian researchers demonstrate that the gut microbiome can help predict the course of multiple sclerosis

    Thursday October 26th 2023

  • Sequana Medical announces additional alfapump data supporting strong and durable clinical profile; PMA on track for year-end submission

    Thursday October 19th 2023

  • SwiftPharma launches ODIN.AI: A groundbreaking AI-augmented antibody discovery platform

    Monday October 9th 2023

Strategic Partners